Dr. Reddy’s Laboratories alleged inflated price-reporting began in October 2003, according to the settlement agreement. The company denies wrongdoing.
Pharmaceutical company to pay $12.9M to settle Texas Medicaid fraud claim
An India-based multinational pharmaceutical manufacturer has agreed to pay $12.9 million to settle claims it reported inflated prices to the Texas Medicaid program, the Texas attorney general said June 8.
The procurement workforce of the future: Scaling teams and impact in an AI-driven era
Presenters: Kyle Snider, MemorialCareMichael Hopkins, Northwestern Memorial HospitalDameka Miller, Trinity HealthGinger Sharp, Legacy HealthKellan Tittle, MBA, People Incorporated Mental Health Services
Comments are closed.